loader from loading.io

The Essential Role Jan Garfinkle has Played in the Medtech Ecosystem — Part 2

MedTech Trailblazers

Release Date: 10/26/2021

Leading With His Heart - A Conversation with Allan Will (Part 2) show art Leading With His Heart - A Conversation with Allan Will (Part 2)

MedTech Trailblazers

Allan Will is one of the founding architects of the medtech industry. Raised by parents who were outspoken supporters of equality and human rights, his desire to help people, passion for science, and business acumen came together in an early job helping Abbott Labs expand into interventional medicine. Just five years later, he was leading DVI, one of the first atherectomy companies, from a 16-person team to a 600-person powerhouse. With a leadership style marked by a patient-centric focus, high expectations, relentless questioning, and an emphasis on authenticity, he helped bring forth...

info_outline
Leading With His Heart - A Conversation with Allan Will (Part 1) show art Leading With His Heart - A Conversation with Allan Will (Part 1)

MedTech Trailblazers

Allan Will is one of the founding architects of the medtech industry. Raised by parents who were outspoken supporters of equality and human rights, his desire to help people, passion for science, and business acumen came together in an early job helping Abbott Labs expand into interventional medicine. Just five years later, he was leading DVI, one of the first atherectomy companies, from a 16-person team to a 600-person powerhouse. With a leadership style marked by a patient-centric focus, high expectations, relentless questioning, and an emphasis on authenticity, he helped bring forth...

info_outline
Sam Conaway: Turning Obstacles into Opportunities - Part 2 show art Sam Conaway: Turning Obstacles into Opportunities - Part 2

MedTech Trailblazers

Sam Conaway is the president of U.S. Cardiology Sales for and the chair of the company’s Close the Gap program, which seeks to eliminate treatment disparities in underserved populations. He has been recognized as one of the most influential Black executives in corporate America (SAVOY Magazine), and in healthcare (BlackDoctor.org), and was the first recipient of the ’s "Pulse-Setter Leader Award" for his commitment to advancing health equity. Sam’s road to these achievements, however, was littered with obstacles that could easily have been roadblocks. Sam grew up poor, in a rough...

info_outline
Sam Conaway: Turning Obstacles into Opportunities - Part 1 show art Sam Conaway: Turning Obstacles into Opportunities - Part 1

MedTech Trailblazers

Sam Conaway is the president of U.S. Cardiology Sales for and the chair of the company’s Close the Gap program, which seeks to eliminate treatment disparities in underserved populations. He has been recognized as one of the most influential Black executives in corporate America (SAVOY Magazine), and in healthcare (BlackDoctor.org), and was the first recipient of the ’s "Pulse-Setter Leader Award" for his commitment to advancing health equity. Sam’s road to these achievements, however, was littered with obstacles that could easily have been roadblocks. Sam grew up poor, in a rough...

info_outline
Kendal Whitlock's Mission to Solve Inequities in Clinical Trials - Part 2 show art Kendal Whitlock's Mission to Solve Inequities in Clinical Trials - Part 2

MedTech Trailblazers

Kendal Whitlock is a problem solver. In her current position as the Head of Digital Optimization, RWE Clinical Trials for Walgreens Boots Alliance, she is working to make it possible for all patients to participate in medical research, regardless of where they live, through decentralized clinical trials and enabling digital technologies. In this second episode of a two-part interview with Andrew Cleeland, CEO of Fogarty Innovation, Kendal describes her career path, explains Walgreens' "game changing" approach to clinical trial recruitment, and reflects on learning from failure and being true...

info_outline
Kendal Whitlock's Mission to Solve Inequities in Clinical Trials show art Kendal Whitlock's Mission to Solve Inequities in Clinical Trials

MedTech Trailblazers

Kendal Whitlock is a problem solver. In her current position as the Head of Digital Optimization, RWE Clinical Trials for Walgreens Boots Alliance, she is working to make it possible for all patients to participate in medical research, regardless of where they live, through decentralized clinical trials and enabling digital technologies. Kendal’s journey has always been about leveraging her passion for scientific evidence with her desire to be a bridge between that information and the communities and people who need it. Shaping her path has been a series of influential mentors – from her...

info_outline
1,800 Patents and Counting: Serial innovator Mir Imran on curiosity, determination, and which problems are worth solving (part 2) show art 1,800 Patents and Counting: Serial innovator Mir Imran on curiosity, determination, and which problems are worth solving (part 2)

MedTech Trailblazers

In this second of two parts, serial innovator and entrepreneur Mir Imran rejoins Andrew Cleeland, CEO of Fogarty Innovation, to discuss his reluctant path through medical school, the inspiration that led him to develop the first automatic implantable cardiac defibrillator, how he views innovation and chooses problems to solve, and the stories behind the founding of Ventritex and Rani Therapeutics. Mir has spent 40 years developing and commercializing breakthrough medical technologies that have saved millions of lives. He has founded more than 20 life science companies including Ventritex,...

info_outline
1,800 Patents and Counting: Serial innovator Mir Imran on curiosity, determination, and which problems are worth solving (part 1) show art 1,800 Patents and Counting: Serial innovator Mir Imran on curiosity, determination, and which problems are worth solving (part 1)

MedTech Trailblazers

Mir Imran has an insatiable interest in unsolved clinical problems and a relentless entrepreneurial drive. The result has been a 40-year career developing and commercializing breakthrough medical technologies that have saved millions of lives. Mir has helped shape the medical device industry, founding more than 20 life science companies including Ventritex, Cardiac Pathways, Percusurge and most recently, Rani Therapeutics. Most of these startups have been acquired by larger companies or gone public. In this episode, Mir joins Andrew Cleeland, CEO of Fogarty Innovation, to share the insights...

info_outline
John Simpson Builds His Successful Career on Constantly Striving for a Better Way (Part 2) show art John Simpson Builds His Successful Career on Constantly Striving for a Better Way (Part 2)

MedTech Trailblazers

World-renowned physician, venture capitalist and prolific entrepreneur, John Simpson, MD, rejoins Andrew Cleeland to discuss the impact he's had on the future generation of medtech innovators. Credited with inventing and commercializing the first over-the-wire balloon catheter used for percutaneous transluminal coronary angioplasty (PTCA) and helping to create the field of interventional cardiology, John also founded and successfully exited numerous companies, including Advanced Cardiovascular Systems (ACS) and Devices for Vascular Intervention (DVI), which were both acquired by Eli Lily;...

info_outline
John Simpson Builds His Successful Career on Constantly Striving for a Better Way  (Part 1) show art John Simpson Builds His Successful Career on Constantly Striving for a Better Way (Part 1)

MedTech Trailblazers

A husband, father, world-renowned physician, venture capitalist and prolific entrepreneur, , MD, has helped revolutionize the field of cardiology via his innovations.   Credited with inventing and commercializing the first over-the-wire balloon catheter used for percutaneous transluminal coronary angioplasty (PTCA) and helping to create the field of interventional cardiology, John also founded and successfully exited numerous companies, including Advanced Cardiovascular Systems (ACS) and Devices for Vascular Intervention (DVI), which were both acquired by Eli Lily; CVIS, acquired by...

info_outline
 
More Episodes

Jan Garfinkle, founder and managing partner of Arboretum Ventures, rejoins Andrew Cleeland as she shares the reasons behind launching the firm and the grit it took to get the company started.

Jan also discusses the pivotal role she played at the National Venture Capital Association (NVCA) to help ensure venture-backed startups could apply for PPP loans during the pandemic, and why the creation of Venture Forward, which promotes diversity in venture funds and portfolio companies, is so important to her.